DekaBank Deutsche Girozentrale’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,950
| Closed | -$183K | – | 1394 |
|
|
2022
Q2 | $183K | Hold |
3,950
| – | – | ﹤0.01% | 1204 |
|
|
2022
Q1 | $273K | Buy |
3,950
+400
| +11% | +$27.6K | ﹤0.01% | 1160 |
|
|
2021
Q4 | $264K | Buy |
3,550
+100
| +3% | +$7.44K | ﹤0.01% | 1221 |
|
|
2021
Q3 | $194K | Hold |
3,450
| – | – | ﹤0.01% | 1216 |
|
|
2021
Q2 | $149K | Hold |
3,450
| – | – | ﹤0.01% | 1279 |
|
|
2021
Q1 | $165K | Hold |
3,450
| – | – | ﹤0.01% | 1216 |
|
|
2020
Q4 | $143K | Hold |
3,450
| – | – | ﹤0.01% | 1229 |
|
|
2020
Q3 | $152K | Buy |
+3,450
| New | +$152K | ﹤0.01% | 1086 |
|
|
2019
Q4 | – | Sell |
-3,550
| Closed | -$214K | – | 1162 |
|
|
2019
Q3 | $214K | Sell |
3,550
-3,550
| -50% | -$214K | ﹤0.01% | 850 |
|
|
2019
Q2 | $595K | Buy |
7,100
+2,700
| +61% | +$226K | ﹤0.01% | 895 |
|
|
2019
Q1 | $396K | Buy |
4,400
+850
| +24% | +$76.5K | ﹤0.01% | 952 |
|
|
2018
Q4 | $253K | Sell |
3,550
-850
| -19% | -$60.6K | ﹤0.01% | 931 |
|
|
2018
Q3 | $396K | Sell |
4,400
-100
| -2% | -$9K | ﹤0.01% | 974 |
|
|
2018
Q2 | $508K | Hold |
4,500
| – | – | ﹤0.01% | 902 |
|
|
2018
Q1 | $358K | Sell |
4,500
-100
| -2% | -$7.96K | ﹤0.01% | 919 |
|
|
2017
Q4 | $183K | Hold |
4,600
| – | – | ﹤0.01% | 945 |
|
|
2017
Q3 | $183K | Hold |
4,600
| – | – | ﹤0.01% | 951 |
|
|
2017
Q2 | $167K | Hold |
4,600
| – | – | ﹤0.01% | 941 |
|
|
2017
Q1 | $144K | Sell |
4,600
-400
| -8% | -$12.5K | ﹤0.01% | 878 |
|
|
2016
Q4 | $168K | Buy |
+5,000
| New | +$168K | ﹤0.01% | 852 |
|
|
2016
Q2 | – | Sell |
-8,000
| Closed | -$228K | – | 1010 |
|
|
2016
Q1 | $228K | Sell |
8,000
-1,500
| -16% | -$42.8K | ﹤0.01% | 826 |
|
|
2015
Q4 | $318K | Buy |
9,500
+100
| +1% | +$3.35K | ﹤0.01% | 787 |
|
|
2015
Q3 | $340K | Buy |
9,400
+300
| +3% | +$10.9K | ﹤0.01% | 767 |
|
|
2015
Q2 | $409K | Buy |
9,100
+300
| +3% | +$13.5K | ﹤0.01% | 738 |
|
|
2015
Q1 | $269K | Buy |
+8,800
| New | +$269K | ﹤0.01% | 835 |
|